A new study finds that combining gelatin sponge with NBCA offers superior control of arterial gastrointestinal bleeding ...

The Roadsaver Carotid Stent System, when used in conjunction with the Nanoparasol Embolic Protection System (EPS), is indicated for the treatment of carotid artery stenosis in patients with elevated ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in ...

However, as with any medical procedure, there are risks involved, such as embolic events that can lead to complications like stroke. To mitigate these risks, TAVR embolic protection devices have ...

With the new analysis, researchers rule out embolic protection for stroke prevention in TAVI, but not everybody has given up.

Incidence of stroke within 72 hours after TAVI or before discharge, if sooner, came out a similar 2.1% with and 2.2% without cerebral embolic protection (P=0.94), reported Rajesh K. Kharbanda ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

The global Embolic Protection Devices Market is valued at $601 million in 2023 and is projected to reach $1,250 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 8.5% from 2024 to ...

Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve replacement. The future of routine cerebral embolic protection in TAVR is in question.

US hospitals pulled back on their use of cerebral embolic protection during TAVI after publication of the PROTECTED TAVR results, a new analysis affirms. The proportion of procedures done with the ...

In IE episodes not complicated by embolic events, in-hospital death was 107/957 (11.2%), versus 94/499 (18.8%) in embolic episodes. The mortality rate was 43/176 (24.4%) in episodes with ischemic ...